Maximum Fair Pricing: Impact on Retail Pharmacies

Maximum Fair Pricing (MFP) took effect Jan. 1, 2026, bringing a historic shift to Medicare drug reimbursement. While the program’s intent is positive—to lower drug costs for Medicare patients—it also introduces new pricing and payment requirements that can add complexity to pharmacy operations.

For many owners and managers, the question isn’t whether MFP will impact the business—it’s how prepared your pharmacy is to adapt. This guide outlines key changes, emerging pressure points, and steps you can take now to stay ahead.

What Is MFP—and Why Does It Matter?

MFP is a provision of the Inflation Reduction Act (IRA) designed to establish fair, lower prices for certain medications commonly used by Medicare recipients. Through negotiation with drug manufacturers, Medicare sets a capped price—the Maximum Fair Price—that it will pay for select medications.

For independent pharmacies, this can mean a potential shift in revenue—especially those serving large Medicare populations—and a need to adapt workflows to include rebate processing, new reporting, and reimbursement tracking.

“One of the biggest challenges we’ve seen is that government agencies were slow to provide meaningful guidance to industry stakeholders,” said Kara Schweigel, manager of compliance solutions for ScriptPro. “That’s concerning for organizations that need time to update policies, evaluate pricing impacts, and make technology changes to stay compliant.”

MFP Rollout Timeline 

The program is being implemented in phases, with new drugs added each year:

• 2026: The first 10 drugs are now under MFP, including Eliquis, Jardiance, Xarelto, and Januvia.
• 2027: Another 15 drugs will be added, including Ozempic, Wegovy, and Ibrance.
• 2028 and beyond: Twenty new drugs will join annually.

As more medications are added, a greater share of your prescription volume and revenue will fall under MFP rules. Preparing in advance gives you space to refine processes instead of reacting under pressure.

How MFP Affects Pharmacies
Independent pharmacies may feel the pressure more acutely due to tighter margins and leaner teams. Key areas that may be impacted include:

• Administrative workload: New rebate tracking and reporting requirements may add operational burden—especially if processes are manual and spread across disconnected systems.

• Inventory and cost control: Managing acquisition costs across patient populations and payer types may become more complex. Supply chain disruptions may also emerge as manufacturers respond to the new pricing environment, potentially causing shortages or delays.

• 340B margin pressure: Pharmacies partnering with 340B covered entitiesmay see tighter margins due to lower Medicare reimbursement limits. For some high-cost specialty drugs, the financial benefits of 340B may diminish, impacting pharmacy revenues.

“As pharmacies prepare for and implement MFP, owners must assess financial and operational strategies,” said Chris Fitzmaurice, vice president of pharmacy strategy and informatics at ScriptPro. “Though MFP is intended to reduce costs for patients, its economic impact must be carefully managed to ensure continued delivery of high-quality care and the health of your business.”

Five Actions to Take Now

Whileadditional guidance fromCenters for Medicare & Medicaid Services (CMS) and the Health Resources and Services Administration (HRSA) is expected, pharmacies can strengthen their readiness with these steps:

1. Enroll with MTF: If you haven’t already,enroll with the CMS Medicare Transaction Facilitator (MTF)¹ to prepare for rebate processing.

2. Educate your team and define processes: Use resources like Beacon’s MFP tools, including the MFP Overview and Rebate Claims Processing webinars², for staff training. Establish internal procedures for monitoring payments and flagging delayed reimbursements. Assess whether your current pharmacy software supports the new MFP requirements—if not, consider upgrading to prevent future bottlenecks.

3. Monitor cash flow daily: With new rebate schedules and possible reimbursement delays, frequent cash flow oversight will be critical. Use technology that provides visibility into revenue, cash position, and reimbursement status. Strong financial management and reconciliation software can help spot delays early and support stable cash flow.

4. Check your reconciliation tools: Make sure your systems can accurately track and verify MFP rebate payments. Use available MFP calculators^3,4 to model and assess how reimbursement changes may affect your bottom line.

Identify new revenue streams: Explore non-dispensing income opportunities, such as travel medicine, chronic care management, or other clinical services, to help offset reduced margins from MFP-affected drugs.

Looking Ahead
MFP represents a long-term change in pharmacy reimbursement. As additional drugs enter the program each year, its influence on margins will grow. Pharmacies that treat MFP not just as a compliance requirement but as a catalyst for improving operations will be better positioned for long-term success.

References

“Welcome to the Medicare Transaction Facilitator,” Centers for Medicare & Medicaid Services.

“MFP On-Demand Webinar Series,” Beacon.

Nelson, Lisa and Rowell, Hannah, “Estimating the Impact of Maximum Fair Prices in 2026,” National Association of Community Health Centers.

IRA Calculator. 340B Health.

About ScriptPro

ScriptPro delivers operational, financial, and clinical solutions backed by 30 years of pharmacy management expertise. Trusted by thousands of retail pharmacies worldwide, we streamline operations, reduce wait times, and lighten staff workload with advanced robotics and integrated software. Our technology automates vial filling, inventory, payments, eligibility, reimbursements and more—freeing pharmacists to focus on patient care.

Qualified AAP buyers receive special pricing.

Contact Sales Director Darin Gleason at (913) 620-8769 or visit scriptpro.com to learn more.